|
Screening
|
Who needs it
|
How often
|
|
Dental caries and other dental problems
|
All children ages 1 year to adolescence*
|
Every six months
|
|
Prevention of dental caries in preschool children
|
Children ages 6 months to 5 years whose primary drinking water source is deficient in fluoride
|
At routine exams; first visit recommended at age 1 year
|
|
Elevated lead levels
|
All children at 1 year and children ages 1 to 5 years who are at average and increased risk
|
Yearly*
|
|
Hearing loss
|
All children
|
At age 4 or 5; before they start school*
|
|
HIV
|
All adolescents at increased risk for infection
|
At routine checkups
|
|
Iron deficiency anemia
|
Children ages 1 to 5 who are at increased risk
|
Yearly
|
|
Obesity
|
Children ages 6 and older
|
At routine exams
|
|
Hearing loss
|
All children
|
At age 4 or 5; before they start school*
|
|
Vision impairment
|
All children
|
At age 4 or 5, and again during adolescence
|
|
Immunization
|
Who needs it
|
How often
|
|
Human papillomavirus (HPV)
|
HPV2 or HPV4, all females& ages 11 and 12 years; HPV4, all males ages 9 to 18 years
|
Three doses total; the second dose given two months after the first dose, and the third dose given six months after the first dose
|
|
Diphtheria
|
All children
|
Dose between ages 4 and 6 years, and booster between ages 11 and 12 years
|
|
Tetanus toxoids
|
All children
|
Dose between ages 4 and 6 years, and booster between ages 11 and 12 years
|
|
Acellular pertussis
|
All children
|
Dose between ages 4 and 6 years, and booster between ages 11 and 12 years
|
|
Measles, mumps, rubella (MMR)
|
All children
|
Second dose recommended between ages 4 and 6 years
|
|
Chickenpox (varicella)
|
All children
|
Second dose recommended between ages 4 and 6 years
|
|
Pneumococcal (polysaccharide)
|
Those at risk
|
Given once 2 or more months after last dose of pneumococcal conjugate vaccine, based on child's medical condition
|
|
Influenza (flu), seasonal
|
All children
|
Yearly, during flu season
|
|
Inactivated poliovirus
|
All children
|
A final dose between ages 4 and 6 years if the series was completed before age 4
|
|
Meningococcal (conjugate)
|
All children
|
One dose between ages 11 and 12, or by age 18 if not previously vaccinated; high-risk groups should receive one dose between ages 2 and 10
|
|
Hepatitis A
|
Those at risk or not fully vaccinated
|
Should be fully vaccinated by age 2; if not, child can be vaccinated at subsequent visits; second dose given at least six months after first dose
|
|
Hepatitis B (Recombivax HB)
|
All children not previously vaccinated
|
Three doses series: For Monovalent Hep B, the second dose is given 4 weeks after the first dose, and the final dose is given 16 weeks after the first dose
Two dose series: Recombivax HB for children ages 11 to 15 years, given at least 4 months apart
|
|
Counseling
|
Who needs it
|
How often
|
|
Behavioral, to prevent sexually transmitted infections
|
All sexually active adolescents
|
At routine exams
|
|
Depression (major depressive disorder)
|
Adolescents ages 12 to 18
|
At routine exams
|